These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 12479561
41. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria. Onyenekwe CC, Kehinde-Agbeyangi TA, Ofor US, Arinola OG. West Afr J Med; 2000; 19(1):23-6. PubMed ID: 10821082 [Abstract] [Full Text] [Related]
43. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Hyde TB, Kruszon-Moran D, McQuillan GM, Cossen C, Forghani B, Reef SE. Clin Infect Dis; 2006 Nov 01; 43 Suppl 3():S146-50. PubMed ID: 16998774 [Abstract] [Full Text] [Related]
45. Changes in the distribution of rubella antibodies in women of childbearing age during the first eight years of a rubella vaccination programme. Hambling MH. J Infect; 1980 Dec 01; 2(4):341-6. PubMed ID: 7185933 [No Abstract] [Full Text] [Related]
47. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002. da Silva e Sá GR, Camacho LA, Stavola MS, Lemos XR, Basílio de Oliveira CA, Siqueira MM. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S722-8. PubMed ID: 21954273 [Abstract] [Full Text] [Related]
48. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine. Riddell M, Senn N, Clements CJ, Hobday L, Cowie B, Kurubi J, Kevin A, Siba P, Reeder JC, Morgan C. Vaccine; 2012 Dec 14; 30(52):7506-12. PubMed ID: 23103194 [Abstract] [Full Text] [Related]
49. [The 1984/85 rubella epidemic in Austria]. Hofmann H, Kunz C, Popow-Kraupp T, Radda AC. Wien Klin Wochenschr; 1986 Mar 07; 98(5):133-7. PubMed ID: 3962315 [Abstract] [Full Text] [Related]
50. Postinfection and postvaccination antirubella immunity. Kańtoch M, Imbs D. Acta Virol; 1986 Sep 07; 30(5):381-9. PubMed ID: 2878585 [Abstract] [Full Text] [Related]
53. Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences. Majlessi F, Batebi A, Shariat M, Rahimi A, Azad TM. East Mediterr Health J; 2008 Sep 07; 14(3):590-4. PubMed ID: 18720623 [Abstract] [Full Text] [Related]
54. Seroprevalence of rubella antibodies among antenatal patients in the Western Cape. Corcoran C, Hardie DR. S Afr Med J; 2005 Sep 07; 95(9):688-90. PubMed ID: 16327929 [Abstract] [Full Text] [Related]
55. Is birth cohort 1985/9-1990/8 a susceptibility window for congenital rubella syndrome in Taiwan? Lin CL, Shih SF, Tsai PH, Liang AC. Taiwan J Obstet Gynecol; 2016 Jun 07; 55(3):368-73. PubMed ID: 27343317 [Abstract] [Full Text] [Related]
57. Rubella Seropositivity in Pregnant Women After Vaccination Campaign in Brazil's Federal District. Nóbrega YKM, de Carvalho BC, Nitz N, Vital TE, Leite FB, Sequeira IJ, Moreira EE, de Andrade JKB, Gandolfi L, Pratesi R, Hecht MM. Viral Immunol; 2017 Nov 07; 30(9):675-677. PubMed ID: 28972455 [Abstract] [Full Text] [Related]
58. Rubella seroprevalence among women aged 15-39 years in Morocco. Caidi H, Bloom S, Azilmaat M, Benjouad A, Reef S, El Aouad R. East Mediterr Health J; 2009 Nov 07; 15(3):526-31. PubMed ID: 19731768 [Abstract] [Full Text] [Related]
60. [Immune protection against rubella in a group of women in Latium]. Fischetti M, Melino C, Venza F. Clin Ter; 1991 Feb 15; 136(3):173-8. PubMed ID: 1827380 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]